Albino, A.P., Kimmelman, C.P., and Parisier, S.C. (1998). Cholesteatoma: A molecular and cellular puzzle. Am. J. Otol. 19, 7‒19.
Albu, S., Babighian, G., and Trabalzini, F. (1998). Prognostic factors in tympanoplasty. Am. J. Otol. 19, 136‒140.
American Academy of Otolaryngology-Head and Neck Surgery, C.O.H.A.E. (1995). Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. AmericanAcademy of Otolaryngology-Head and Neck Surgery Ffoundation, Inc. Otolaryngol. Head. Neck Surg. 113, 186‒187.
Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. (1999). Notch signaling: cell fate control and signal integration in development. Science 284, 770‒776.
Ashcroft, M., and Vousden, K.H. (1999). Regulation of p53 stability. Oncogene 18, 7637‒7643.
Baráth, K., Huber, A.M., Stämpfli, P., Varga, Z., and Kollias, S. (2011). Neuroradiology of cholesteatomas. AJNR. Am. J. Neuroradiol. 32, 221‒229.
Bared, A., and Angeli, S.I. (2010). Malleus handle: determinant of success in ossiculoplasty. Am. J. Otolaryngol. 31, 235‒240.
Beatus, P., Lundkvist, J., Öberg, C., and Lendahl, U. (1999). The notch 3 intracellular domain represses notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters. Development 126, 3925‒3935.
Beatus, P., Lundkvist, J., Öberg, C., Pedersen, K., and Lendahl, U. (2001). The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity. Mech. Dev. 104, 3‒20.
Blanpain, C., Lowry, W.E., Pasolli, H.A., and Fuchs, E. (2006). Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev. 20, 3022‒3035.
Bray, S.J. (2016). Notch signalling in context. Nat. Rev. Mol. Cell Biol. 17, 722‒ 735.
Briddell, J.W., Levi, J.R., and OʼReilly, R.C. (2018). Chronic Otitis Media. In Infections of the Ears, Nose, Throat, and Sinuses, (Cham: Springer International Publishing), pp. 57‒66.
Chavan, S.S., Jain, P. V., Vedi, J.N., Rai, D.K., and Kadri, H. (2014). Ossiculoplasty: a prospective study of 80 cases. Iran. J. Otorhinolaryngol. 26, 143‒150.
Chung, J.H., Lee, S.H., Park, C.W., Kim, K.R., Tae, K., Kang, S.-H., Oh, Y.H., and Pyo, J.Y. (2015). Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma. Otolaryngol. Head. Neck Surg. 153, 1024‒1030.
Dornhoffer, J.L., and Gardner, E. (2001). Prognostic factors in ossiculoplasty: a statistical staging system. Otol. Neurotol. 22, 299‒304.
Dubrulle, F., Souillard, R., Chechin, D., Vaneecloo, F.M., Desaulty, A., and Vincent, C. (2006). Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology 238, 604‒610.
Hamed, M.A., Nakata, S., Sayed, R.H., Ueda, H., Badawy, B.S., Nishimura, Y., Kojima, T., Iwata, N., Ahmed, A.R., Dahy, K., et al. (2016). Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives. Clin. Exp. Otorhinolaryngol. 9, 298‒308.
Hamed, M.A., Nakata, S., Shiogama, K., Suzuki, K., Sayed, R.H., Nishimura, Y., Iwata, N., Sakurai, K., Badawy, B.S., Inada, K.-I., et al. (2017). Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity. Clin. Exp. Otorhinolaryngol. 10, 213‒220.
Huisman, M.A., De Heer, E., and Grote, J.J. (2003). Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol. 123, 377‒382.
Jackler, R.K., and Gralapp, C. (2020). Ear Surgery Illustrated: A comprehensive Atlas of Otologic Microsurgical Techniques (New York: Thieme).
Jeunen, G., Desloovere, C., Hermans, R., and Vandecaveye, V. (2008). The value of magnetic resonance imaging in the diagnosis of residual or recurrent acquired cholesteatoma after canal wall-up tympanoplasty. Otol. Neurotol. 29, 16‒18.
Kaether, C., Haass, C., and Steiner, H. (2006). Assembly, trafficking and function of γ-secretase. Neurodegener. Dis. 3, 275‒283.
Kageyama, R., Ohtsuka, T., Hatakeyama, J., and Ohsawa, R. (2005). Roles of bHLH genes in neural stem cell differentiation. Exp. Cell Res. 306, 343‒348.
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., and Morishima, K. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353‒D361.
Kerckhoffs, K.G.P., Kommer, M.B.J., van Strien, T.H.L., Visscher, S.J.A., Bruijnzeel, H., Smit, A.L., and Grolman, W. (2016). The disease recurrence rate after the canal wall up or canal wall down technique in adults. Laryngoscope 126, 980‒987.
Kolev, V., Mandinova, A., Guinea-Viniegra, J., Hu, B., Lefort, K., Lambertini, C., Neel, V., Dummer, R., Wagner, E.F., and Dotto, G.P. (2008). EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat. Cell Biol. 10, 902‒911.
Kösling, S., and Bootz, F. (2001). CT and MR imaging after middle ear surgery. Eur. J. Radiol. 40, 113‒118.
Kuo, C.-L. (2015). Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope 125, 234‒ 240.
Kuo, C.-L., Shiao, A.-S., Yung, M., Sakagami, M., Sudhoff, H., Wang, C.-H., Hsu, C.-H., and Lien, C.-F. (2015a). Updates and knowledge gaps in cholesteatoma research. Biomed Res. Int. 2015, 854024.
Kuo, C.-L., Liao, W.-H., and Shiao, A.-S. (2015b). A review of current progress in acquired cholesteatoma management. Eur. Arch. Otorhinolaryngol. 272, 3601‒3609.
Lefort, K., and Dotto, G.P. (2004). Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. Semin. Cancer Biol. 14, 374‒386.
Lefort, K., Mandinova, A., Ostano, P., Kolev, V., Calpini, V., Kolfschoten, I., Devgan, V., Lieb, J., Raffoul, W., Hohl, D., et al. (2007). Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinases. Genes Dev. 21, 562‒577.
Lehmann, P., Saliou, G., Brochart, C., Page, C., Deschepper, B., Vallée, J.N., and Deramond, H. (2009). 3T MR imaging of postoperative recurrent middle ear cholesteatomas: value of periodically rotated overlapping parallel lines with enhanced reconstruction diffusion-weighted MR imaging. AJNR. Am. J. Neuroradiol. 30, 423‒427.
Li, P.M.M.C., Linos, E., Gurgel, R.K., Fischbein, N.J., and Blevins, N.H. (2013). Evaluating the utility of non-echo-planar diffusion-weighted imaging in the preoperative evaluation of cholesteatoma: a meta-analysis. Laryngoscope 123, 1247‒1250.
Lingam, R.K., and Bassett, P. (2017). A Meta-Analysis on the Diagnostic Performance of Non-Echoplanar Diffusion-Weighted Imaging in Detecting Middle Ear Cholesteatoma: 10 Years On. Otol. Neurotol. 38, 521‒528.
Lingam, R.K., Nash, R., Majithia, A., Kalan, A., and Singh, A. (2016). Non- echoplanar diffusion weighted imaging in the detection of post-operative middle ear cholesteatoma: navigating beyond the pitfalls to find the pearl. Insights Imaging 7, 669‒678.
Liu, W., Yin, T., Ren, J., Li, L., Xiao, Z., Chen, X., and Xie, D. (2014). Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium. Eur. Arch. Oto-Rhino-Laryngology 271, 265‒ 273.
Martin, T.P.C., Weller, M.D., Kim, D.S., and Smith, M.C.F. (2009). Results of primary ossiculoplasty in ears with an intact stapes superstructure and malleus handle: inflammation in the middle ear at the time of surgery does not affect hearing outcomes. Clin. Otolaryngol. 34, 218‒224.
Más-Estellés, F., Mateos-Fernández, M., Carrascosa-Bisquert, B., Facal de Castro, F., Puchades-Román, I., and Morera-Pérez, C. (2012). Contemporary non-echo-planar diffusion-weighted imaging of middle ear cholesteatomas. Radiographics 32, 1197‒1213.
Matsuda, K., Tono, T., Kojima, H., Yamamoto, Y., Sakagami, M., Mishiro, Y., Hinohira, Y., and Okuno, T. (2018). Practicality analysis of the staging system proposed by the Japan Otological Society for acquired middle ear cholesteatoma: A multicenter study of 446 surgical cases in Japan. Auris. Nasus. Larynx 45, 45‒ 50.
Mishiro, Y., Sakagami, M., Adachi, O., and Kakutani, C. (2009). Prognostic factors for short-term outcomes after ossiculoplasty using multivariate analysis with logistic regression. Arch. Otolaryngol. Head. Neck Surg. 135, 738‒741.
Mishiro, Y., Sakagami, M., Kitahara, T., and Kakutani, C. (2010). Prognostic factors of long-term outcomes after ossiculoplasty using multivariate analysis. Eur. Arch. Otorhinolaryngol. 267, 861‒865.
Moon, I.S., Song, M.H., Kim, H.-N., Chung, M.-H., Lee, W.-S., and Lee, H.-K. (2007). Hearing results after ossiculoplasty using Polycel prosthesis. Acta Otolaryngol. 127, 20‒24.
Motamed, M., Powe, D., Kendall, C., Birchall, J.P., and Banerjee, A.R. (2002). p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma. Clin. Otolaryngol. Allied Sci. 27, 505‒508.
Nicolas, M., Wolfer, A., Raj, K., Kummer, J.A., Mill, P., van Noort, M., Hui, C., Clevers, H., Dotto, G.P., and Radtke, F. (2003). Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 33, 416‒421.
Olszewska, E., Rutkowska, J., Minovi, A., Sieskiewicz, A., Rogowski, M., and Dazert, S. (2013). The role of p21 and p53 proteins in congenital cholesteatoma. Otol. Neurotol. 34, 266‒274.
Pinchot, S.N., Jaskula-Sztul, R., Ning, L., Peters, N.R., Cook, M.R., Kunnimalaiyaan, M., and Chen, H. (2011). Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer 117, 1386‒1398.
Profant, M., Sláviková, K., Kabátová, Z., Slezák, P., and Waczulíková, I. (2012). Predictive validity of MRI in detecting and following cholesteatoma. Eur. Arch. Otorhinolaryngol. 269, 757‒765.
Quaranta, N., Taliente, S., Coppola, F., and Salonna, I. (2015). Cartilage ossiculoplasty in cholesteatoma surgery: hearing results and prognostic factors. Acta Otorhinolaryngol. Ital. Organo Uff. Della Soc. Ital. Di Otorinolaringol. e Chir. Cerv.-Facc. 35, 338‒342.
Rangarajan, A., Talora, C., Okuyama, R., Nicolas, M., Mammucari, C., Oh, H., Aster, J.C., Krishna, S., Metzger, D., Chambon, P., et al. (2001). Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 20, 3427‒3436.
Shinoda, H., and Huang, C.C. (1995). Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope 105, 1232‒1237.
Tono, T., Sakagami, M., Kojima, H., Yamamoto, Y., Matsuda, K., Komori, M., Hato, N., Morita, Y., and Hashimoto, S. (2017). Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society. Auris. Nasus. Larynx 44, 135‒140.
Toyama, C., Leite, C. da C., Baraúna Filho, I.S., Brito Neto, R.V. de, Bento, R.F., Cerri, G.G., and Gebrim, E.M.M.S. (2008). The role of magnetic resonance imaging in the postoperative management of cholesteatomas. Braz. J. Otorhinolaryngol. 74, 693‒696.
Umit, T., Ozgur, Y., Bilgehan, G., Volkan, S.A., and Sezim, S.A. (2010). Results of primary ossiculoplasty and prognostic factors in canal wall-down tympanoplasty. J. Craniofac. Surg. 21, 407‒410.
Venail, F., Bonafe, A., Poirrier, V., Mondain, M., and Uziel, A. (2008). Comparison of echo-planar diffusion-weighted imaging and delayed postcontrast T1-weighted MR imaging for the detection of residual cholesteatoma. AJNR. Am. J. Neuroradiol. 29, 1363‒1368.
De Vos, C., Gersdorff, M., and Gérard, J.-M. (2007). Prognostic factors in ossiculoplasty. Otol. Neurotol. 28, 61‒67.
Yamamoto, N., Ogino, E., Hiraumi, H., Sakamoto, T., and Ito, J. (2010). Outcome of ossiculoplasty in Kyoto University Hospital. Acta Otolaryngol. Suppl. 6489, 11‒15.
Yamashita, K., Yoshiura, T., Hiwatashi, A., Obara, M., Togao, O., Matsumoto, N., Kikuchi, K., and Honda, H. (2013). High-resolution three-dimensional diffusion-weighted imaging of middle ear cholesteatoma at 3.0 T MRI: usefulness of 3D turbo field-echo with diffusion-sensitized driven-equilibrium preparation (TFE-DSDE) compared to single-shot echo-planar imaging. Eur. J. Radiol. 82, e471-5.
Yugawa, T., Handa, K., Narisawa-Saito, M., Ohno, S., Fujita, M., and Kiyono, T. (2007). Regulation of Notch1 gene expression by p53 in epithelial cells. Mol. Cell. Biol. 27, 3732‒3742.
Yung, M., and Vowler, S.L. (2006). Long-term results in ossiculoplasty: an analysis of prognostic factors. Otol. Neurotol. 27, 874‒881.
Yung, M., Tono, T., Olszewska, E., Yamamoto, Y., Sudhoff, H., Sakagami, M., Mulder, J., Kojima, H., İncesulu, A., Trabalzini, F., et al. (2017). EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma. J. Int. Adv. Otol. 13, 1‒8.
切替⼀郎 (2013). ⽿の⽣理. 新⽿⿐咽喉科学, 加我君孝(編). (東京都: 南⼭堂), pp.35.